Winfried S Wels

9PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 07, 2025
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.

Lisa Marie Reindl, Lida Jalili, Tobias Bexte

|Mar 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.

F Strassheimer, P Elleringmann, G Ludmirski

|Apr 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.

Meenakshi Hegde, Shoba Navai, Christopher DeRenzo

|Feb 28, 2024
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

Jiri Eitler, Wiebke Rackwitz, Natalie Wotschel

Pageof 2